DocGo Inc. Equity Method Investment, Other than Temporary Impairment
DocGo Inc. (DCGO) reported Equity Method Investment, Other than Temporary Impairment of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Income Statement › Other Income
us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment · last filed 2026-08-17
- DocGo Inc. equity method investment, other than temporary impairment for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- DocGo Inc. equity method investment, other than temporary impairment for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- DocGo Inc. equity method investment, other than temporary impairment for the quarter ending 2025-06-30 was $38.82K.
- DocGo Inc. equity method investment, other than temporary impairment for the quarter ending 2025-03-31 was $40.70K.
- DocGo Inc. equity method investment, other than temporary impairment for fiscal 2025 was $552.76K, a 74.90% increase from fiscal 2024.
- DocGo Inc. equity method investment, other than temporary impairment for fiscal 2024 was $316.04K, a 7.95% decline from fiscal 2023.
- DocGo Inc. equity method investment, other than temporary impairment for fiscal 2023 was $343.34K.
| Period end | Equity Method Investment, Other than Temporary Impairment 3 month | Equity Method Investment, Other than Temporary Impairment 6 month | Equity Method Investment, Other than Temporary Impairment 12 month |
|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-17 | $0.00 10-Q · filed 2026-08-17 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-11 | ||
| 2025-12-31 | $552.76K 10-K · filed 2026-03-16 | ||
| 2025-06-30 | $38.82K 10-Q · filed 2026-08-17 | $79.52K 10-Q · filed 2026-08-17 | |
| 2025-03-31 | $40.70K 10-Q · filed 2026-05-11 | ||
| 2024-12-31 | $316.04K 10-K · filed 2026-03-16 | ||
| 2023-12-31 | $343.34K 10-K · filed 2026-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |